Bessemer Group Inc. lifted its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 32.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,338 shares of the financial services provider’s stock after acquiring an additional 3,263 shares during the period. Bessemer Group Inc.’s holdings in Aflac were worth $861,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of AFL. Valmark Advisers Inc. increased its stake in Aflac by 0.7% in the first quarter. Valmark Advisers Inc. now owns 23,179 shares of the financial services provider’s stock valued at $1,495,000 after purchasing an additional 153 shares during the period. Good Life Advisors LLC lifted its position in Aflac by 0.6% during the 1st quarter. Good Life Advisors LLC now owns 24,699 shares of the financial services provider’s stock worth $1,594,000 after acquiring an additional 159 shares during the period. Laidlaw Wealth Management LLC grew its stake in shares of Aflac by 1.8% in the 4th quarter. Laidlaw Wealth Management LLC now owns 9,385 shares of the financial services provider’s stock valued at $675,000 after purchasing an additional 165 shares during the last quarter. Stonebridge Capital Advisors LLC increased its holdings in shares of Aflac by 12.5% in the fourth quarter. Stonebridge Capital Advisors LLC now owns 1,491 shares of the financial services provider’s stock valued at $107,000 after purchasing an additional 166 shares during the period. Finally, Kinneret Advisory LLC raised its stake in shares of Aflac by 2.3% during the first quarter. Kinneret Advisory LLC now owns 8,441 shares of the financial services provider’s stock worth $544,000 after purchasing an additional 190 shares during the last quarter. 66.56% of the stock is owned by institutional investors and hedge funds.
Aflac Stock Down 0.5 %
Shares of NYSE AFL opened at $74.45 on Tuesday. Aflac Incorporated has a 1 year low of $56.03 and a 1 year high of $78.43. The firm’s 50 day moving average price is $71.80 and its 200 day moving average price is $68.34. The firm has a market cap of $44.23 billion, a P/E ratio of 9.95, a price-to-earnings-growth ratio of 2.28 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.07 and a current ratio of 0.07.
Aflac Announces Dividend
Analysts Set New Price Targets
Several equities analysts have issued reports on AFL shares. 58.com reissued a “reiterates” rating on shares of Aflac in a research note on Friday, June 9th. Citigroup raised their price target on Aflac from $69.00 to $76.00 and gave the company a “neutral” rating in a report on Wednesday, August 9th. Truist Financial increased their target price on shares of Aflac from $70.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. JPMorgan Chase & Co. increased their target price on shares of Aflac from $72.00 to $74.00 and gave the company a “neutral” rating in a report on Wednesday, August 2nd. Finally, StockNews.com started coverage on shares of Aflac in a report on Thursday, August 17th. They issued a “hold” rating for the company. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $76.00.
Read Our Latest Stock Analysis on Aflac
Insider Buying and Selling
In related news, Director Joseph L. Moskowitz sold 500 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $69.60, for a total transaction of $34,800.00. Following the sale, the director now owns 27,085 shares in the company, valued at $1,885,116. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, SVP Albert Riggieri sold 7,649 shares of Aflac stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $76.09, for a total transaction of $582,012.41. Following the transaction, the senior vice president now owns 26,210 shares in the company, valued at approximately $1,994,318.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 500 shares of Aflac stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $69.60, for a total transaction of $34,800.00. Following the transaction, the director now owns 27,085 shares in the company, valued at approximately $1,885,116. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 26,815 shares of company stock worth $2,036,019. 0.90% of the stock is owned by insiders.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- What is ChatGPT Stock? How to Invest in It
- Nordstrom: 3 Reasons the Pre-Earnings Dip Is an Opportunity
- Insider Trades May Not Tell You What You Think
- Is Now the Time to Buy these 3 Most Downgraded Stocks?
- What is a Non-Fungible Token (NFT)? Definition and How it Works
- 3 Semiconductor Stocks At Risk From China’s Economic Slowdown
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.